Posts in category: Uncategorized

Preliminary results from a landmark clinical trial to prevent Alzheimer’s disease (AD) symptoms show that an investigational anti-amyloid drug, solanezumab, did not demonstrate a statistically significant slowing of cognitive decline associated with AD when initiated prior to the stage of clinical impairment.

Myelodysplastic syndromes (MDS) are a diverse group of bone marrow disorders in which immature stem cells do not mature to become red blood cells, white blood cells or platelets. Patients with higher-risk MDS tend to have poorer outcomes, a greater chance of developing acute myeloid leukemia and few effective treatment options.

A new study of more than 800,000 people has found that in the U.S., COVID “long haulers” were more likely to be older and female, with more chronic conditions than people in a comparison group who—after getting COVID—did not have diagnosed long COVID or any of the symptoms associated with long COVID. The findings are published in the March issue of Health Affairs.

While the COVID-19 pandemic upended everything in the world, it also became a powerful catalyst for innovations that made remote delivery of health care and services—including dentistry—possible.

Black Americans and white Americans may receive different benefits from their networks of friends, family ties and other relationships, according to a University of Michigan researcher.

Being able to take a quick walk to a nearby food retail store may be a significant factor in long-term weight loss after bariatric surgery, new research suggests.

Replaying prior experiences when learning something new can improve the brain’s ability to make future plans and preserve memories of the past, finds new research by UCL neuroscientists.

During the first year of the pandemic, states in the U.S. with high rates of death from COVID-19 saw significant increases in other causes of death, too, including cardiovascular disease, dementia, diabetes, and influenza. That’s according to findings from the University of Pennsylvania, Boston University, and the Robert Wood Johnson Foundation published recently in the journal PLOS ONE.

The biological function of the C-reactive protein, CRP, has long been unknown. Researchers at Linköping University in Sweden now show that this protein has a beneficial function in systemic lupus erythematosus, SLE, an inflammatory disease. But this is true only for one of CRP’s two forms, according to the study published in Journal of Autoimmunity.

Nearly 270,000 people in the United States are diagnosed with breast cancer each year.